Glycosylated hemoglobin Test
- UID
- MFG/IVD/2023/000103_b6105050d659a5053cf9411bcc288040_e2631fb90ee80425f71ce6ca8561609f
- Device class
- Class B
- Brand name
- RF-IgM
- License holder
- Genovik Biotech Pvt. Ltd.
- Approving authority
- Rajasthan
- Product information
- Genovik Glycosylated hemoglobin (RF-IgM) is applicable to the quantitative detection of the concentration of HbA1c in human whole blood
Glycosylated hemoglobin Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000103_b6105050d659a5053cf9411bcc288040_e2631fb90ee80425f71ce6ca8561609f. This device is marketed under the brand name RF-IgM. The license holder is Genovik Biotech Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is Rajasthan.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.